2 -Glycoprotein I ( 2 -GPI) is proteolytically cleaved by plasmin in domain V (nicked  2 -GPI), being unable to bind to phospholipids. This cleavage may occur in vivo and elevated plasma levels of nicked  2 -GPI were detected in patients with massive plasmin generation and fibrinolysis turnover. In this study, we report higher prevalence of elevated ratio of nicked  2 -GPI against total  2 -GPI in patients with ischemic stroke (63%) and healthy subjects with lacunar infarct (27%) when compared to healthy subjects with normal findings on magnetic resonance imaging (8%), suggesting that nicked  2 -GPI might have a physiologic role beyond that of its parent molecule in patients with thrombosis. Several inhibitors of extrinsic fibrinolysis are known, but a negative feedback regulator has not been yet documented. We demonstrate that nicked  2 -GPI binds to Glu-plasminogen with K D of 0.37 ؋ 10 ؊6 M, presumably mediated by the interaction between the fifth domain of nicked  2 -GPI and the fifth kringle domain of Glu-plasminogen. Nicked  2 -GPI also suppressed plasmin generation up to 70% in the presence of tissue plasminogen activator, plasminogen, and fibrin. Intact  2 -GPI lacks these properties. These data suggest that  2 -GPI/plasmin-nicked  2 -GPI controls extrinsic fibrinolysis via a negative feedback pathway loop.
Introduction 2 -Glycoprotein I ( 2 -GPI), also known as apolipoprotein H, is a phospholipid-binding plasma protein. Phospholipid-bound  2 -GPI is one of the major target antigens for antiphospholipid antibodies 1-3 present in patients with antiphospholipid syndrome (APS), an autoimmune disorder characterized by arterial/venous thrombosis and pregnancy morbidity. 4  2 -GPI has 5 homologous short consensus repeats, designated as domains I to V. Domains of  2 -GPI structurally resemble each other, except that domain V has an extra C-terminal loop and a positively charged lysine cluster. In 1993, Hunt et al 5 reported that  2 -GPI is proteolytically cleaved between Lys317 and Thr318 in domain V (nicked  2 -GPI), being unable to bind to phospholipids. This cleavage is generated by factor Xa or by plasmin, with plasmin being more effective. 6 A large number of reports have detailed the in vitro properties of  2 -GPI as a natural anticoagulant/procoagulant regulator by inhibiting phospholipid-dependent reactions, such as prothrombinase and tenase activity on platelets or phospholipid vesicles, 7,8 factor XII activation, 9 and anticoagulant activity of activated protein C. 10,11 Apart from specific hemostatic functions,  2 -GPI activates lipoprotein lipase, 12 lowers the triglyceride level, 13 binds to oxidized low-density lipoprotein to prevent the progression of atherosclerosis, 14 and binds to nonself particles or apoptotic bodies to allow their clearance. [15][16][17] Little attention has been given to the functions of the nicked form of  2 -GPI because its phospholipidbinding activity was thought to exert the physiologic or pathologic functions of  2 -GPI.Fibrinolytic reactions ...
E l e c t r o n i c s Materials & Components Research L a b o r a t o r i e s Nippon M i n i n g Co., Ltd., 3-17-35 N i i z o -m i n a m i , Toda, Saitama, J a p a n 335.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.